Fedora Pharmaceuticals Inc. is dedicated to the discovery and development of novel antimicrobial drug candidates that will address the challenge of antimicrobial resistance (AMR). Fedora is interested in exploring partnerships and/or licensing agreements with industry and academia to support its growing pipeline of product candidates. For more information on business development opportunities at Fedora, please contact Fedora at info@fedorapharma.com.
View Top Employees from Fedora Pharmaceuticals Inc.Website | http://www.fedorapharma.com |
Revenue | $1 million |
Employees | 5 (2 on RocketReach) |
Founded | 2012 |
Address | 11629 105 Ave NW, Edmonton, Alberta, CA |
Phone | (780) 757-5401 |
Technologies |
JavaScript,
HTML,
Twitter
+8 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Manufacturing General, Biopharma, Manufacturing, Biotechnology, Health Care, Science and Engineering, Medical, Pharmaceutical |
Web Rank | 14 Million |
Competitors | Amphoraxe Life Sciences Inc., Cyclenium Pharma Inc., Oxalys Pharmaceuticals, Inc. |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Fedora Pharmaceuticals Inc. employee's phone or email?
The Fedora Pharmaceuticals Inc. annual revenue was $1 million in 2024.
Sameeh Salama is the Chief Scientific Officer of Fedora Pharmaceuticals Inc..
2 people are employed at Fedora Pharmaceuticals Inc..
Fedora Pharmaceuticals Inc. is based in Edmonton, Alberta.
The NAICS codes for Fedora Pharmaceuticals Inc. are [32541, 3254, 32, 325].
The SIC codes for Fedora Pharmaceuticals Inc. are [28, 283].